Royalty Pharma Common Stock Net 2019-2024 | RPRX
Royalty Pharma common stock net for the quarter ending December 31, 2024 was $0.000B, a 0% increase year-over-year.
- Royalty Pharma common stock net for 2024 was $0B, a 0% decline from 2023.
- Royalty Pharma common stock net for 2023 was $0B, a 0.93% increase from 2022.
- Royalty Pharma common stock net for 2022 was $0B, a 0.94% increase from 2021.